Analyst Price Target is $6.00
▲ +383.87% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for NewAge in the last 3 months. The average price target is $6.00, with a high forecast of $6.00 and a low forecast of $6.00. The average price target represents a 383.87% upside from the last price of $1.24.
Current Consensus is
The current consensus among 2 polled investment analysts is to buy stock in NewAge. This rating has held steady since June 2021, when it changed from a Hold consensus rating.
NewAge Inc is engaged in the business of developing, marketing, selling, and distributing a portfolio of healthy products. It offers a portfolio of healthy products with its brands across platforms, such as health & wellness, inner & outer beauty, and nutrition & weight management. Its partner companies include ARIIX, Noni, LIMU, and ZENNOA. The company was founded by Neil Fallon on April 26, 2010 and is headquartered in Denver, CO.